Yokohama, Japan

Hiroshi Iguchi


Average Co-Inventor Count = 10.9

ph-index = 2

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 1993-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroshi Iguchi: Innovator in Pharmaceutical Chemistry

Introduction

Hiroshi Iguchi is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug compounds. With a total of 3 patents to his name, Iguchi's work has the potential to impact the treatment of various diseases.

Latest Patents

Iguchi's latest patents include groundbreaking research on isocoumarin derivatives and their applications in drugs. One of his notable inventions is a 4-hydroxypyridine derivative, which is useful for treating circulatory diseases. This derivative is represented by a specific formula, wherein R can be a methyl group or an isopropyl group. The method for preparing this derivative involves cultivating a strain belonging to Streptomyces karnatakensis. Additionally, he has disclosed a pharmaceutical composition that includes this compound and a method for treating circulatory diseases by administering the compound to patients.

Career Highlights

Throughout his career, Hiroshi Iguchi has worked with reputable organizations, including Mercian Corporation and the Biseibutsu Kagaku Kenkyu Kai. His experience in these companies has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Iguchi has collaborated with esteemed colleagues such as Takeo Yoshioka and Shin-ichi Hirano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Hiroshi Iguchi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…